This bill matters because it aims to strengthen the integrity of vaccine development and increase public trust in vaccines. By making it a crime to commit fraud in vaccine clinical trials and removing legal shields for companies that do so, it seeks to ensure that all data presented to the government about vaccine safety and effectiveness is truthful.
If this bill becomes law, it could lead to greater scrutiny of vaccine trials and potentially provide more recourse for individuals who believe they were harmed due to fraudulent data. However, it could also introduce more legal uncertainty for vaccine manufacturers, potentially affecting the speed and willingness of companies to develop new vaccines, especially during future public health emergencies. If it doesn't pass, the existing liability protections for vaccine manufacturers would remain in place under various circumstances, and there would be no specific federal criminal charge for vaccine trial fraud.
KEY PROVISIONS
4AI-extracted
PROVISION 01
Creates a new federal crime for medical research companies or sponsors who make fraudulent statements or conceal material data from the U.S. government regarding clinical vaccine trials.
This provision directly targets dishonesty in vaccine research by imposing severe penalties, aiming to deter fraud.
PROVISION 02
Amends the Federal Food, Drug, and Cosmetic Act to prevent or revoke an Emergency Use Authorization (EUA) if based on fraudulent statements or concealed information related to vaccine trial data.
This ensures that emergency authorizations for vaccines are only granted when based on truthful and complete information, protecting public health.
PROVISION 03
Amends the Public Health Service Act to remove liability protections for companies (covered persons) for 'covered countermeasures' (like vaccines during emergencies) if fraudulent statements were made or material information concealed in clinical trial data.
This significantly alters a key legal shield that protects companies during public health emergencies, creating accountability for fraud.
PROVISION 04
Amends the National Vaccine Injury Compensation Program (NVICP) to allow civil lawsuits against vaccine manufacturers if fraud is determined, specifically for COVID-19 vaccines with no time limit for such claims.
This opens new legal avenues for individuals to seek damages outside the existing federal compensation program, particularly for COVID-19 related injuries linked to fraud.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
This bill matters because it aims to strengthen the integrity of vaccine development and increase public trust in vaccines. By making it a crime to commit fraud in vaccine clinical trials and removing legal shields for companies that do so, it seeks to ensure that all data presented to the government about vaccine safety and effectiveness is truthful.
If this bill becomes law, it could lead to greater scrutiny of vaccine trials and potentially provide more recourse for individuals who believe they were harmed due to fraudulent data. However, it could also introduce more legal uncertainty for vaccine manufacturers, potentially affecting the speed and willingness of companies to develop new vaccines, especially during future public health emergencies. If it doesn't pass, the existing liability protections for vaccine manufacturers would remain in place under various circumstances, and there would be no specific federal criminal charge for vaccine trial fraud.
KEY PROVISIONS
AI-extracted
high
Creates a new federal crime for medical research companies or sponsors who make fraudulent statements or conceal material data from the U.S. government regarding clinical vaccine trials.
This provision directly targets dishonesty in vaccine research by imposing severe penalties, aiming to deter fraud.
high
Amends the Federal Food, Drug, and Cosmetic Act to prevent or revoke an Emergency Use Authorization (EUA) if based on fraudulent statements or concealed information related to vaccine trial data.
This ensures that emergency authorizations for vaccines are only granted when based on truthful and complete information, protecting public health.
high
Amends the Public Health Service Act to remove liability protections for companies (covered persons) for 'covered countermeasures' (like vaccines during emergencies) if fraudulent statements were made or material information concealed in clinical trial data.
This significantly alters a key legal shield that protects companies during public health emergencies, creating accountability for fraud.
high
Amends the National Vaccine Injury Compensation Program (NVICP) to allow civil lawsuits against vaccine manufacturers if fraud is determined, specifically for COVID-19 vaccines with no time limit for such claims.
This opens new legal avenues for individuals to seek damages outside the existing federal compensation program, particularly for COVID-19 related injuries linked to fraud.
The Secretary of Health and Human Services shall provide a vaccine manufacturer or sponsor 30 days to refute a determination of fraudulent statements or concealed information.
5 days
A vaccine manufacturer or sponsor must provide any requested document to the Secretary not more than five days before a hearing.
No termination date
Civil actions against a vaccine manufacturer for COVID-19 vaccines due to fraudulent statements or concealed information may be made at any time.
Fined under this title, imprisoned not more than 5 years, or both.
A medical research company or sponsor
GLOSSARY
AI-written
Clinical Vaccine Trial
Organized research studies involving human volunteers to test if a vaccine is safe and effective before it can be widely used.
Medical Research Company or Sponsor
The organization or business that plans, pays for, and oversees the testing of new medicines or vaccines.
Fraudulent Statement
A dishonest or intentionally false claim made to mislead or deceive.
Conceals Material Data
Hides or keeps secret important facts or information that would be crucial for making a decision.
Emergency Use Authorization (EUA)
A special permission from the FDA to allow the use of unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Right to Try Act
A federal law that allows patients with life-threatening conditions to try experimental treatments that are still in clinical trials and not yet fully approved by the FDA.
National Vaccine Injury Compensation Program (NVICP)
A federal program that provides compensation to people who have suffered an injury or death from certain vaccines.
ACTION TIMELINE
2 EVENTS
MAY 29, 25
Introduced in House
INTROREFERRAL
MAY 29, 25
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Medical products like vaccines, drugs, or devices designated by the government for use in a public health emergency, often with special liability protections.
